ID Number		309
Study Type		Epidemiology
Model		INTERPHONE - New Zealand National site 900, 1800 MHz (NMT, GSM, W-CDMA) mobile phone use and correlation with brain, acoustic nerve, parotid gland tumors
Details		Participating countries are Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan, New Zealand, Norway, Sweden and the UK. In order to maximise the power of finding a risk if it exists, the studies are mainly focused on tumours in relatively young people (30-59  who had the highest prevalence of mobile phone use 5 to 10 years ago) and on regions within the participating countries with longest and highest use of mobile phones. It is expected that the studies will include about 6000 cases of gliomas and meningiomas (both benign and malignant), 1000 cases of acoustic neurinoma, 600 cases of parotid gland tumours and their respective controls. The primary source of information is an in-person computer assisted interview (CAPI) conducted by a trained interviewer. Retrospective and prospective validation studies are being carried out to investigate the accuracy of self-reported use of mobile phones by comparing questionnaire answers to information from records of mobile telephone companies and to information recorded by software modified phones. An RF exposure index is being constructed based on information from the questionnaire, as well as on technical information on the characteristics of the network and of the telephones used and on the time period. Start date 2000, end date 2005
Findings		Ongoing
Status		Ongoing
Start Date
End Date
Principal Investigator		University of Otago, New Zealand
Funding Agency		EU, INTERPHONE (IARC) coordinated studies, MMF, GSM Association
Country		NEW ZEALAND
References
Comments		UICC acts as a firewall for funding by MMF and GSMA - see http://www.iarc.fr/pageroot/UNITS/RCA4.html for details)